(Q35998626)

11 August 2017

1 reference

title

Sense and antisense: therapeutic potential of oligonucleotides and interference RNA in asthma and allergic disorders (English)

1 reference

11 August 2017

1 reference

Howard A Ball

1

1 reference

11 August 2017

Michael R Van Scott

series ordinal

2

1 reference

11 August 2017

Cynthia B Robinson

series ordinal

3

1 reference

11 August 2017

1 December 2004

1 reference

Clinical Reviews in Allergy & Immunology

11 August 2017

1 reference

11 August 2017

27

1 reference

11 August 2017

207-217

1 reference

11 August 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1385/criai:27:3:207

11 August 2017

0 references

cites work

Treatment of allergic airway inflammation and hyperresponsiveness by antisense-induced local blockade of GATA-3 expression

1 reference

12 December 2020

Changing patterns in asthma morbidity and mortality.

1 reference

12 December 2020

Towards optimal design of second-generation immunomodulatory oligonucleotides

1 reference

12 December 2020

Antisense and sensibility

1 reference

12 December 2020

Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

1 reference

12 December 2020

Fomivirsen - a phosphorothioate oligonucleotide for the treatment of CMV retinitis

1 reference

12 December 2020

Role of gob-5 in mucus overproduction and airway hyperresponsiveness in asthma

1 reference

12 December 2020

Local administration of antisense phosphorothioate oligonucleotides to the c-kit ligand, stem cell factor, suppresses airway inflammation and IL-4 production in a murine model of asthma

1 reference

12 December 2020

RNA interference: it's a small RNA world

1 reference

12 December 2020

An overview of progress in antisense therapeutics

1 reference

12 December 2020

Inhibition of antigen-induced eosinophilia and airway hyperresponsiveness by antisense oligonucleotides directed against the common beta chain of IL-3, IL-5, GM-CSF receptors in a rat model of allergic asthma

1 reference

12 December 2020

A hitchhiker's guide to antisense and nonantisense biochemical pathways

1 reference

12 December 2020

Inhibition of allergic inflammation in the airways using aerosolized antisense to Syk kinase

1 reference

12 December 2020

Antisense DNAs as targeted therapeutics for cancer: no longer a dream.

1 reference

12 December 2020

Microarray profile of differentially expressed genes in a monkey model of allergic asthma

1 reference

12 December 2020

Pulmonary bioavailability of a phosphorothioate oligonucleotide (CGP 64128A): comparison with other delivery routes

1 reference

12 December 2020

Importance of nucleotide sequence and chemical modifications of antisense oligonucleotides

1 reference

12 December 2020

A review of the issues in the pharmacokinetics and toxicology of phosphorothioate antisense oligonucleotides

1 reference

12 December 2020

Antiproliferative activity of G-quartet-forming oligonucleotides with backbone and sugar modifications.

1 reference

12 December 2020

A nonantisense sequence-selective effect of a phosphorothioate oligodeoxynucleotide directed against the epidermal growth factor receptor in A431 cells

1 reference

12 December 2020

Absorption, distribution, metabolism, and excretion of a respirable antisense oligonucleotide for asthma

1 reference

12 December 2020

Antisense therapy in oncology: new hope for an old idea?

1 reference

12 December 2020

DNA antisense therapy for asthma in an animal model

1 reference

12 December 2020

Animal models of occupational asthma

1 reference

12 December 2020

Identifiers

DOI

10.1385/CRIAI:27:3:207

1 reference

Dimensions Publication ID

11 August 2017

0 references

1 reference